老年人对预防认知衰退的培训工具的看法
Celine Cammarata1,2,3, Elaine Wethington1,4, Adam K Anderson1,2
1Department of Psychology, Cornell University, Ithaca, New York, USA.
Informatics for health & social care
|October 27, 2024
概括
年长的成年人不自愿使用认知训练工具,经常发现它们不愉快. 未来的干预措施必须与用户的偏好保持一致,以吸引有机的活动来促进认知健康.
科学领域:
- 老年学是一门学科.
- 认知心理学 认知心理学
- 数字健康数字健康
背景情况:
- 计算机化认知训练平台为老年人提供了保持认知健康的潜力.
- 这些工具的商业可用性引发了关于它们在没有外部处方的情况下被采用的问题.
研究的目的:
- 通过认知训练探索社区生活的老年人自我启动的经验.
- 了解影响数字认知健康工具参与的因素.
主要方法:
- 与13名年龄在58-85岁之间的成年人进行了半结构面试.
- 参与者包括大学退休人员和公共住房居民.
- 用专题分析来分析采访数据.
主要成果:
- 没有参与者报告自愿使用认知训练平台.
- 之前的用户描述了认知训练的负面经验.
- 偏好本质上愉快和有机的活动显著塑造了参与度.
结论:
- 老年人的优先事项和目前可用的认知培训干预措施之间存在显著的不匹配.
- 访问和兴趣带来了挑战,特别是对于低收入和少数民族的老年人来说.
- 未来的干预措施应优先考虑与用户偏好保持一致,以提高效率.
更多相关视频
06:58Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
Published on: January 24, 2020
7.3K
07:31A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
Published on: February 13, 2020
6.9K
相关概念视频
Cognitive Development During Adulthood
61
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
61
Alzheimer's Disease: Treatment
165
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
165
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
101
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
101
Alzheimer's Disease: Overview
449
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
449
Aging
37
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
37
